国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Danio rerio Cryptochrome DASH (cry-dash), partial CSB-YP679760DIL
CSB-EP679760DIL
CSB-BP679760DIL
CSB-MP679760DIL
CSB-EP679760DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Anoctamin-6 (ANO6), partial CSB-YP679761HU
CSB-EP679761HU
CSB-BP679761HU
CSB-MP679761HU
CSB-EP679761HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig GPI-anchor transamidase (PIGK), partial CSB-YP679762PI
CSB-EP679762PI
CSB-BP679762PI
CSB-MP679762PI
CSB-EP679762PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Suberites domuncula 40S ribosomal protein SA CSB-YP679763FOW
CSB-EP679763FOW
CSB-BP679763FOW
CSB-MP679763FOW
CSB-EP679763FOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tscherskia triton Beta-2 adrenergic receptor (ADRB2), partial CSB-YP679764TBAK1
CSB-EP679764TBAK1
CSB-BP679764TBAK1
CSB-MP679764TBAK1
CSB-EP679764TBAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cyclin-D4-2 (CYCD4-2) CSB-YP679765OFG
CSB-EP679765OFG
CSB-BP679765OFG
CSB-MP679765OFG
CSB-EP679765OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant DegV domain-containing protein CSB-YP679766SML
CSB-EP679766SML
CSB-BP679766SML
CSB-MP679766SML
CSB-EP679766SML-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP679767SBAH
CSB-EP679767SBAH
CSB-BP679767SBAH
CSB-MP679767SBAH
CSB-EP679767SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Alkyl hydroperoxide reductase subunit C (ahpC) CSB-YP679768SBAH
CSB-EP679768SBAH
CSB-BP679768SBAH
CSB-MP679768SBAH
CSB-EP679768SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Inosine-5'-monophosphate dehydrogenase (guaB) CSB-YP679769SBAH
CSB-EP679769SBAH
CSB-BP679769SBAH
CSB-MP679769SBAH
CSB-EP679769SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus UPF0133 protein SH2533 (SH2533) CSB-YP679770SBAH
CSB-EP679770SBAH
CSB-BP679770SBAH
CSB-MP679770SBAH
CSB-EP679770SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Thymidylate kinase (tmk) CSB-YP679771SBAH
CSB-EP679771SBAH
CSB-BP679771SBAH
CSB-MP679771SBAH
CSB-EP679771SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Bifunctional protein GlmU (glmU) CSB-YP679772SBAH
CSB-EP679772SBAH
CSB-BP679772SBAH
CSB-MP679772SBAH
CSB-EP679772SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 33 kDa chaperonin (hslO) CSB-YP679773SBAH
CSB-EP679773SBAH
CSB-BP679773SBAH
CSB-MP679773SBAH
CSB-EP679773SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Pyridoxal biosynthesis lyase pdxS (pdxS) CSB-YP679774SBAH
CSB-EP679774SBAH
CSB-BP679774SBAH
CSB-MP679774SBAH
CSB-EP679774SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus ATP-dependent Clp protease ATP-binding subunit ClpC (clpC), partial CSB-YP679775SBAH
CSB-EP679775SBAH
CSB-BP679775SBAH
CSB-MP679775SBAH
CSB-EP679775SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX) CSB-YP679776SBAH
CSB-EP679776SBAH
CSB-BP679776SBAH
CSB-MP679776SBAH
CSB-EP679776SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 50S ribosomal protein L7/L12 (rplL) CSB-YP679777SBAH
CSB-EP679777SBAH
CSB-BP679777SBAH
CSB-MP679777SBAH
CSB-EP679777SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus 30S ribosomal protein S7 (rpsG) CSB-YP679778SBAH
CSB-EP679778SBAH
CSB-BP679778SBAH
CSB-MP679778SBAH
CSB-EP679778SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus haemolyticus FMN-dependent NADPH-azoreductase (azo1) CSB-YP679779SBAH
CSB-EP679779SBAH
CSB-BP679779SBAH
CSB-MP679779SBAH
CSB-EP679779SBAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>